Little is known on the role of distinct B-cell subtypes in human malignancies. We have recently performed a multiplex characterization of B cells in patient-derived tumor-associated tissues, documenting the activation and antigen-driven differentiation of B cells in metastatic lymph nodes and neoplastic lesions. Here we discuss the role of B lymphocytes as antigen-presenting cells and catalysts of T cell-based immunotherapies in view of these findings.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3805648PMC
http://dx.doi.org/10.4161/onci.25237DOI Listing

Publication Analysis

Top Keywords

flavors tumor-associated
4
cells
4
tumor-associated cells
4
cells role
4
role distinct
4
distinct b-cell
4
b-cell subtypes
4
subtypes human
4
human malignancies
4
malignancies performed
4

Similar Publications

The polarizing nature of fructose.

Sci Signal

December 2024

Science Signaling, AAAS, Washington, DC 20005, USA.

Dietary fructose skews tumor-associated macrophages toward a pro-cancer phenotype in colorectal tumors.

View Article and Find Full Text PDF

Hexokinase 2 senses fructose in tumor-associated macrophages to promote colorectal cancer growth.

Cell Metab

November 2024

Key Laboratory of Epigenetic Regulation and Intervention, Chinese Academy of Sciences, Beijing 100101, China; College of Life Sciences, University of Chinese Academy of Sciences, Beijing 100049, China. Electronic address:

Fructose is associated with colorectal cancer tumorigenesis and metastasis through ketohexokinase-mediated metabolism in the colorectal epithelium, yet its role in the tumor immune microenvironment remains largely unknown. Here, we show that a modest amount of fructose, without affecting obesity and associated complications, promotes colorectal cancer tumorigenesis and growth by suppressing the polarization of M1-like macrophages. Fructose inhibits M1-like macrophage polarization independently of fructose-mediated metabolism.

View Article and Find Full Text PDF
Article Synopsis
  • Cancer cells have a high demand for sugars, and researchers developed glycopolymer-like nanoparticles that target specific receptors on cancer-associated macrophages to enhance their effectiveness in fighting tumors.
  • These nanoparticles, created through a carbonization process, can alter immune cell polarization and cellular metabolism, promoting a transition from M2 (immunosuppressive) to M1 (pro-inflammatory) macrophages, which helps overcome tumor defenses.
  • In models of glioblastoma and pancreatic cancer, these nanoparticles not only induced cancer cell death but also improved the effectiveness of immunotherapy by remodeling the tumor microenvironment, activating immune responses, and facilitating the activity of cytotoxic T lymphocytes and dendritic cells.
View Article and Find Full Text PDF

Aggressive glioma exhibits a poor survival rate. Increased tumor aggression is linked to both tumor cells and tumor-associated macrophages (TAMs), which induce pro-aggression, invasion, and metastasis. Imperatively, for effective treatment, it is important to target both glioma cells and TAMs.

View Article and Find Full Text PDF

Polymeric nanoformulations aimed at cancer metabolism reprogramming with high specificity to inhibit tumor growth.

Biomater Sci

September 2024

Key Laboratory of Biomedical Polymers of Ministry of Education & Department of Chemistry, Wuhan University, Wuhan 430072, P.R. China.

Metabolic disorders of cancer cells create opportunities for metabolic interventions aimed at selectively eliminating cancer cells. Nevertheless, achieving this goal is challenging due to cellular plasticity and metabolic heterogeneity of cancer cells. This study presents a dual-drug-loaded, macrophage membrane-coated polymeric nanovesicle designed to reprogram cancer metabolism with high specificity through integrated extracellular and intracellular interventions.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!